← Back to headlines
Isomorphic Labs Raises $2.1 Billion for AI Drug Discovery
Isomorphic Labs, a DeepMind spinout backed by Google, has successfully raised $2.1 billion to advance its efforts in AI-driven drug discovery. The substantial funding aims to scale its cutting-edge research in developing new medicines.
12 May, 15:21 — 12 May, 16:17
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (42/100)3 sources25/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left
Center2
Center (2)
marketwatchbloomberg
Right1
Right (1)
channel-news-asia
Far R
Geographic diversity— 2 regions9/34
US2Singapore1
Sources
Showing 2 of 3 sources
marketwatchMostly Factual87d ago
Google AI legend raises big money for startup targeting this cutting-edge goal
Demis Hassabis is the co-founder and CEO of Google’s DeepMind artificial-intelligence lab, which has spun out a startup called Isomorphic Labs to use AI to accelerate the creation of new drugs.
By William Gavin
Read full article →channel-news-asiaMostly Factual87d ago
Google-backed Isomorphic raises $2.1 billion to scale AI-driven drug discovery
Read full article →Coverage Timeline
First report: bloomberg · 12 May, 13:15|Full coverage: 3 · 3h|Window: 3h
Left-leaningCenterRight-leaning
Related Stories
Swades Foundation CEO Advocates for Tech Impact in Remote Regions
35m ago
Pizza Franchisor Ordered to Refund Man After Highway Project Acquires Site
35m ago
China's AI Development Faces Bottleneck Due to Lack of Quality Training Data
35m ago
Thailand Launches Siam Silica Framework to Boost Semiconductor Industry
35m ago